epilepsy

Epilepsy affects approximately 50 million people globally, with up to 30% of patients failing to achieve seizure control with available antiseizure medications. Second- and third-generation antiseizure medications, surgical resection, neuromodulation, and the ketogenic diet are key therapeutic options. Genetic characterisation is increasingly guiding precision treatment in paediatric epilepsy syndromes and treatment-refractory disease.